IL13RA2 was shown to be overexpressed in activated HSC, and blocking the IL13 receptor reduced hepatic fibrosis development caused by non-alcoholic steatohepatitis (NASH)38. The gene discussed is IL13RA2; the disease is metabolic dysfunction-associated steatohepatitis.